The differential effect of intravenous iron in patients with non-dialysis chronic kidney disease in terms of fibroblast growth factor 23, phosphate, bone metabolism …

X Kassianides - 2024 - etheses.whiterose.ac.uk
Background: Modern intravenous iron preparations (eg ferric derisomaltose (FDI), ferric
carboxymaltose (FCM)) are commonly used in non-dialysis-dependent chronic kidney …

Prise en charge de la carence martiale au cours de la maladie rénale chronique: mise au point et proposition d'un algorithme

C Guibergia, F Brazier, G Choukroun - Néphrologie & Thérapeutique, 2022 - Elsevier
Résumé La carence martiale est très fréquente au cours de la maladie rénale chronique, y
compris avant le stade de dialyse. Il s' agit d'un facteur indépendant de morbi-mortalité chez …

Management of iron deficiency in chronic kidney disease: Review and proposed algorithm

C Guibergia, F Brazier, G Choukroun - Néphrologie & Thérapeutique, 2022 - jle.com
La carence martiale est tres fré quente au cours de la maladie ré nale chronique, y compris
avant le stade de dialyse. Il s' agit d'un facteur indé pendant de morbi-mortalité chez les …

Anemia ferropénica: impacto em saúde pública e importância do seu diagnóstico

LSN Fernandes - 2022 - repositorio.ul.pt
A deficiência de ferro é uma das causas mais comuns de anemia. Esta deficiência e a
anemia que decorre dela, conhecida como anemia ferropénica em Portugal e anemia …

High-dose intravenous iron use in hemodialysis patients: Results from the National Health Insurance System (2019–2020) in South Korea

AJ Cho, Y Bae, M Kim, DH Kim, YK Lee, HC Park - 2024 - researchsquare.com
Background Intravenous (IV) iron administration is used widely for treating anemia in
hemodialysis (HD) patients. In this study, we investigated the safety of IV iron therapy in this …

Značaj određivanja hepcidina-25 i odabranih genetskih varijanti u lečenju anemije kod pacijenata u terminalnoj bubrežnoj slabosti

MМ Savković - Универзитет у Београду, 2022 - nardus.mpn.gov.rs
Novija istraživanja ukazuju da u okviru sistemske regulacije homeostaze gvožđa koja se
ostvaruje složenim mehanizmima, značajnu ulogu ima hepcidin-25, peptid koji se sintetiše u …

Anemia in Chronic Kidney Disease

MP Martinez Cantarin… - Approaches to Chronic …, 2022 - Springer
Anemia in chronic kidney disease is a common complication associated with significant
morbidity including decreased quality of life and mortality. Erythropoietin deficiency and …

Comparing high-dose and low-dose intravenous iron therapy in hemodialysis patients in Benha city, Egypt

MET Ibrahim, HG AbdEl-Salam, MS Fathy… - Journal of The …, 2020 - journals.lww.com
Background Since the introduction of erythropoiesis-stimulating agents for the management
of anemia in patients with chronic kidney disease (CKD), intravenous (iv) iron has been …

Хорошо ли мы лечим дефицит железа при анемии ХБП у пациентов на гемодиализе? Связь между ферритином сыворотки и 1-годичной выживаемостью

ЛИ Аниконова, ВЮ Ряснянский, ГД Шостка… - Нефрология и …, 2020 - elibrary.ru
Актуальность: до сих пор отсутствует единое представление о том, какая стратегия
использования внутривенных препаратов железа для больных ХБП 5Д является …

Anemia in Chronic Kidney Disease

MPM Cantarin, UEM Outschoorn - Approaches to Chronic …, 2021 - books.google.com
Anemia is defined as an absolute reduction of the total number of circulating red blood cells.
Clinically, anemia is diagnosed by a decrease in hemoglobin (Hgb) concentration, decrease …